Drug Detail

Information about Keytruda

Generic Name
Pembrolizumab
IND
MK-3475
Brand Name (US)
Keytruda
Manufacturer
Merck
Drug Type
Anti-PD-1 antibody
Delivery
Intravenous
Approval Status
Approved for a non-GIST application
Indications
Melanoma
Overall Strategy
Immune system
Strategy
Stimulate the immune system
Drug Category
PD-1 inhibitor


Links

 

Prescribing information
   

 

Keytruda website
   

Trials of this drug


Trial results


Search for this drug/combination in:

ClinicalTrials.gov

ASCO

Pubmed